CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$75,309,289
+$565,560 QoQ
Shares Held
923,927
-22.5% QoQ
Ownership
0.654%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 497 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ARWR ranks #23 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ARWR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,309,289 | 923,927 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $74,743,729 | 1,192,085 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $89,873,404 | 1,353,719 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $46,418,711 | 1,345,860 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $18,497,771 | 1,170,745 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $19,133,136 | 1,017,720 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $19,504,330 | 1,006,935 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $25,843,442 | 994,361 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $28,135,393 | 983,755 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $25,886,957 | 845,979 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $22,704,746 | 844,985 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $40,832,803 | 1,145,059 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $29,402,405 | 1,157,575 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $46,175,248 | 1,138,443 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $36,485,316 | 1,103,943 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $37,987,646 | 1,078,888 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $49,932,400 | 1,085,723 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $69,607,972 | 1,049,894 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $64,349,909 | 1,030,753 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $83,370,338 | 1,006,645 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $63,680,609 | 960,347 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $71,166,691 | 927,495 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $39,387,714 | 914,717 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $31,507,450 | 729,508 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $20,226,058 | 703,026 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||